查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1931272

神經外科植入耗材市場（按產品類型、材料、最終用戶和應用分類），全球預測（2026-2032）

Neurosurgery Implant Consumable Market by Product Type, Material, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，神經外科植入耗材市場價值將達到 16.5 億美元，到 2026 年將成長至 17.9 億美元，到 2032 年將達到 32.2 億美元，年複合成長率為 10.05%。

關鍵市場統計數據
基準年 2025 16.5億美元
預計年份：2026年 17.9億美元
預測年份 2032 32.2億美元
複合年成長率 (%) 10.05%

對神經外科植入耗材環境進行全面概述，詳細闡述臨床需求、供應壓力和影響其應用發展的創新方向。

神經外科植入耗材的市場環境呈現出快速的技術進步、不斷變化的臨床通訊協定以及日益成長的採購壓力等特點，這為產品開發商、醫院採購人員和專科診所製定了戰略重點。臨床醫生越來越傾向於選擇兼俱動態性能、良好操作特性以及與微創手術流程相容性的植入和耗材。因此，製造商正增加對材料科學、模組化設計和術中效率的投入，以縮短手術時間並改善患者預後。

材料創新、數位整合和流程改善如何共同重塑神經外科耗材的競爭格局和臨床應用

神經外科植入耗材領域正經歷變革性的轉變，這得益於材料科學、數位化整合和外科技術創新的整合。多聚合物和碳纖維複合材料憑藉其卓越的強度重量比和影像相容性，重新定義了傳統的性能指標；而積層製造技術則實現了以往難以企及的複雜設計。這些進步催生了更符合患者解剖結構和手術流程的新型器械幾何形狀，加速了其臨床應用。

評估關稅壓力如何推動神經外科供應鏈的結構調整、採購收緊和本地製造投資

對醫療設備原料和成品徵收關稅，對製造商、醫療系統和採購商而言都是複雜的問題。關稅政策會改變原料和零件的相對成本，從而影響上游採購決策，並可能促使供應鏈從易受影響的地區轉向多元化的供應基地。這可能會促使製造商採取雙重採購安排和庫存管理策略，以降低政策突變帶來的風險。

一個整合的細分框架，揭示了產品類型、材料選擇、最終用戶環境和臨床應用如何決定產品採用路徑和開發者優先順序。

神經外科植入耗材市場的細分揭示了需求的細微差別，反映了不同產品、材料、終端用戶和應用領域中的臨床需求和性能權衡。產品類型包括顱骨板、止血鉗、椎間融合器、椎弓骨釘和脊椎棒。顱骨板本身又分為永久性和可吸收性兩種選擇，外科醫師需要權衡長期耐用性和可吸收性的利弊。止血鉗依出血特性、組織親和性和操作性能，分為膠原蛋白基、明膠基和氧化再生纖維素配方。椎間器有複合材料、PEEK 和鈦合金三種材質，每種材質的透射性和動態性能各不相同。椎弓骨釘的選擇則體現在膨脹螺釘和傳統螺釘之間的權衡，反映了即時穩定性與簡化植入之間的取捨。脊柱棒通常由不銹鋼或鈦製成，選擇依據是剛度特性、疲勞壽命和成像的考慮。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和市場接受度差距正在影響市場進入和擴大策略。

區域趨勢對神經外科植入耗材的監管路徑、採購行為和臨床應用曲線有顯著影響。美洲的特點是擁有高度集中的先進臨床中心、一體化醫院系統和成熟的醫療保險報銷體系。這些因素共同創造了一種市場環境，在這種環境下，能夠顯著縮短手術時間和降低併發症發生率的創新技術能夠迅速被市場接受，而集團採購組織在供應商選擇方面也擁有舉足輕重的影響力。

現有製造商、專業創新者和夥伴關係主導策略如何重新定義競爭優勢和採購決策

神經外科植入耗材領域的競爭格局由成熟製造商、專業化的中型企業和敏捷的創新者共同構成​​。歷史悠久的跨國醫療設備公司憑藉其廣泛的分銷網路和穩固的臨床關係，持續在醫院系統和專科診所中保持市場地位。這些公司通常擁有全面的產品系列組合、完善的監管支援和臨床培訓項目，這為尋求同等市場覆蓋率的新進入者設定了很高的進入門檻。

將臨床創新、供應鏈韌性和商業模式演進連結起來，創造長期價值的可操作策略重點

產業領導者應採取多管齊下的策略，平衡創新投資、營運韌性和商業性紀律。首先，優先投資於能夠解決明確臨床挑戰的材料和設計，例如提高影像相容性、縮短手術時間以及提升微創手術的易用性。將產品開發與臨床醫生共同設計以及有針對性的臨床試驗結合，可以加快產品實用化速度。其次，透過供應商多元化、盡可能進行區域性製造地以及利用先進的庫存和需求預測工具提高供應鏈視覺性，增強供應鏈韌性。這種方法既能維持服務水平，又能降低關稅和貿易波動帶來的風險。

我們採用嚴格的三角調查方法，結合臨床訪談、監管分析和供應鏈評估，以確保獲得可靠、可操作的見解。

本分析採用三角測量法，整合質性和量性數據，以得出可靠且可重複的調查方法結果。為了解關鍵相關人員的實踐模式、採購動機和未滿足的需求，研究人員與外科醫生、採購人員和臨床營運經理進行了結構化訪談。此外，研究人員還透過同行評審的臨床文獻、監管文件和技術白皮書收集了二手證據，用於檢驗臨床聲明，並梳理醫療設備的分類和材料特性。

對神經外科植入耗材的韌性和機會進行臨床、材料和商業性因素的簡要綜合分析

現代神經外科植入耗材市場瞬息萬變，臨床需求、材料創新和採購複雜性交織其中。該行業的特點是聚合物科學和器械幾何形狀的持續創新、與數位化手術平台的深度整合，以及在貿易政策不斷變化的背景下對價值鏈穩健性的日益重視。臨床領導者關注的是能夠顯著提高術中效率和病患療效的解決方案，而相關人員則要求提供價值證明和可靠的供應保障。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 神經外科植入耗材市場（依產品類型分類）

  • 頭骨板
  • 止血劑
  • 椎弓骨釘
  • 脊椎桿

9. 神經外科植入耗材市場（依材料分類）

  • 複合聚合物
    • 生物可吸收聚合物
    • 碳纖維複合材料
  • PEEK
  • 不銹鋼
  • 鈦

第10章 神經外科植入耗材市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專科診所
    • 神經內科診所
    • 脊椎中心

第11章 神經外科植入耗材市場（依應用領域分類）

  • 顱骨
    • 重組
    • 創傷修復
  • 脊椎
    • 頸椎
    • 腰椎
    • 胸椎
  • 創傷
    • 硬腦膜修復
    • 顱骨骨折修復
  • 瘤
    • 切片檢查引導
    • 腫瘤植入

第12章 神經外科植入耗材市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 神經外科植入耗材市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國神經外科植入耗材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國神經外科植入耗材市場

第16章：中國神經外科植入耗材市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Aesculap Implant Systems, LLC
  • B. Braun SE
  • Boston Scientific Corporation
  • Craniotech Solutions Pvt. Ltd.
  • DePuy Synthes, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Neuro France Implants SAS
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Penumbra, Inc.
  • Siora Surgicals Pvt. Ltd.
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-7B550E008DFC

The Neurosurgery Implant Consumable Market was valued at USD 1.65 billion in 2025 and is projected to grow to USD 1.79 billion in 2026, with a CAGR of 10.05%, reaching USD 3.22 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.65 billion
Estimated Year [2026] USD 1.79 billion
Forecast Year [2032] USD 3.22 billion
CAGR (%) 10.05%

A comprehensive orientation to the neurosurgery implant consumables environment detailing clinical imperatives, supply pressures, and innovation vectors shaping adoption

The neurosurgery implant consumables landscape is characterized by rapid technological refinement, shifting clinical protocols, and evolving procurement pressures that together define the strategic priorities of product developers, hospital procurement leaders, and specialty clinics. Clinicians increasingly demand implants and consumables that balance biomechanical performance with favorable handling characteristics and compatibility with minimally invasive workflows. Consequently, manufacturers are investing in materials science, modularity, and intraoperative efficiency to reduce procedural time and improve patient outcomes.

At the same time, supply chain resiliency and regulatory compliance have moved to the forefront of strategic planning. Manufacturers and health systems are navigating raw material sourcing, sterilization logistics, and traceability requirements while aligning product portfolios with evidence-based clinical guidelines. As a result, market participants who couple clinical insight with robust supply and quality frameworks are finding greater traction with integrated delivery networks and specialty centers. Moving forward, the interplay of clinical need, material innovation, and operational rigor will determine which technologies become standard of care and which will be niche offerings.

How materials innovation, digital integration, and procedural evolution are jointly reshaping competitive dynamics and clinical adoption in neurosurgery consumables

The neurosurgery implant consumables sector is undergoing transformative shifts driven by converging innovations in materials science, digital integration, and procedural technique. Composite polymers and carbon fiber composites are redefining expected performance metrics by offering strength-to-weight advantages alongside imaging compatibility, while additive manufacturing enables design complexity that was previously unattainable. These advances are unlocking new device form factors that better conform to patient anatomy and surgical workflows, thereby accelerating clinical acceptance.

Concurrently, digital tools such as intraoperative navigation, advanced imaging, and surgical planning platforms are tightly coupling with implant design to enable precision placement and personalized constructs. Transitioning from one-size-fits-most approaches toward patient-specific solutions, these technologies drive demand for implants and consumables that are compatible with navigation and imaging modalities. Moreover, reimbursement and regulatory trends are incentivizing shorter hospital stays and outpatient procedures, prompting manufacturers to prioritize products that reduce operative time and complications. Taken together, these shifts are reshaping competitive dynamics and raising the bar for manufacturers seeking durable clinical and commercial differentiation.

Assessing how tariff-driven pressures are catalyzing supply chain reconfiguration, procurement rigor, and localized manufacturing investments within the neurosurgery supply chain

The imposition of tariffs on medical device inputs and finished goods introduces a complex set of considerations for manufacturers, health systems, and purchasers. Tariff policies affect upstream sourcing decisions by altering the relative cost of raw materials and components, which in turn can shift supply chains away from vulnerable geographies and toward diversified supplier bases. As a result, manufacturers may accelerate dual-sourcing arrangements and stockkeeping strategies to mitigate exposure to sudden policy changes.

In parallel, tariffs create pressure on pricing strategies across commercial channels. Procurement teams within hospitals and ambulatory surgery centers respond by intensifying supplier negotiations, exploring alternative materials or product families, and prioritizing total cost of ownership over unit price. Regulatory compliance and customs processes can also lengthen lead times, prompting more conservative inventory policies and a heightened focus on demand forecasting accuracy. Importantly, the tariff environment incentivizes nearshoring and localized manufacturing investments for those organizations with the capital to reconfigure production footprints, while smaller suppliers may pursue partnerships or licensing models to maintain market access. Ultimately, the cumulative effect of tariffs is less about uniform cost increases and more about a rebalancing of supply chain strategies, pricing discipline, and capital allocation toward resilience and responsiveness.

An integrated segmentation framework revealing how product type, material choice, end user environment, and clinical application define adoption pathways and developer priorities

Segmentation in the neurosurgery implant consumables domain reveals nuanced demand pockets that reflect clinical need and performance trade-offs across product, material, end user, and application vectors. Product type distinctions include cranial plates, hemostatic agents, interbody cages, pedicle screws, and spinal rods; cranial plates themselves bifurcate into permanent and resorbable options as surgeons weigh long-term durability against resorption benefits. Hemostatic agents span collagen-based, gelatin-based, and oxidized regenerated cellulose formulations, each selected according to bleeding profile, tissue affinity, and handling characteristics. Interbody cages are offered in composite, PEEK, and titanium variants, which present different radiographic profiles and biomechanical behaviors. Pedicle screw choices contrast expandable screws with traditional designs, reflecting trade-offs between immediate purchase stability and simplified insertion. Spinal rods are commonly manufactured in stainless steel or titanium, with selection driven by stiffness profiles, fatigue life, and imaging considerations.

Material segmentation further refines performance expectations and clinical compatibility. Composite polymers encompass bioresorbable polymers and carbon fiber composites, while PEEK, stainless steel, and titanium remain foundational choices for their established mechanical properties and regulatory histories. End user segmentation clarifies procurement and usage environments, ranging from ambulatory surgery centers to hospitals and specialty clinics; within hospitals the private and public distinction affects purchasing cycles and capital approvals, whereas specialty clinics such as neurology clinics and dedicated spine centers prioritize procedures with repeatable workflows and predictable consumable consumption. Application segmentation frames the clinical scenarios in which implants are deployed, stretching from cranial reconstruction and trauma repair to spinal interventions across cervical, lumbar, and thoracic regions; trauma use cases include dural repair and skull fracture repair, while tumor-related applications involve biopsy guidance and oncology implant strategies. Integrating these segmentation layers offers a multidimensional view of product positioning, clinical fitment, and procurement pathways that is essential for targeted product development and commercial planning.

Regional dynamics and adoption differentials across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine market entry and scaling tactics

Regional dynamics materially influence the regulatory pathways, procurement behaviors, and clinical adoption curves for neurosurgery implant consumables. The Americas are characterized by a high concentration of advanced clinical centers, consolidated hospital systems, and mature reimbursement frameworks. These factors create a market environment where innovation that demonstrably reduces procedural time and complication rates can gain rapid acceptance, and where group purchasing organizations exert significant influence over supplier selection.

Europe, Middle East & Africa presents heterogeneous regulatory and procurement landscapes that demand regionally tailored market approaches. Western European markets typically emphasize evidence generation, health technology assessment, and clinician-driven adoption, while certain Middle Eastern markets prioritize infrastructure expansion and rapid capability building. In parts of Africa, access and supply chain reliability remain central constraints, influencing the prioritization of robust, cost-efficient solutions. Asia-Pacific exhibits a wide spectrum of maturity; advanced markets emphasize local manufacturing and regulatory harmonization, while emerging economies are adopting implants and consumables more selectively, often driven by growing hospital capacity and investments in surgical training. Across all regions, strategic imperatives include navigating local regulatory requirements, building clinical evidence aligned with regional practice patterns, and structuring commercial models that reflect procurement channel diversity and reimbursement realities.

How legacy manufacturers, specialized innovators, and partnership-driven strategies are redefining competitive advantage and procurement decisions

Competitive positioning in the neurosurgery implant consumables arena is shaped by a blend of enduring legacy manufacturers, specialized mid-tier players, and agile innovators. Legacy multinational device companies continue to leverage broad distribution networks and established clinical relationships to maintain presence across hospital systems and specialty clinics. These firms often couple comprehensive product portfolios with extensive regulatory support and clinical training programs, creating high barriers for new entrants seeking equivalent reach.

Specialized manufacturers and focused startups, by contrast, differentiate through rapid iteration on materials and device geometry, closer collaboration with key opinion leaders, and targeted pilot programs in high-value centers. These entities are adept at translating clinical feedback into product refinements and can therefore capture niche segments more quickly. Strategic partnerships, co-development agreements, and targeted acquisitions remain common playbooks for scaling technologies and accessing new channels. Additionally, partnerships between implant manufacturers and digital-navigation or intraoperative imaging providers are becoming increasingly relevant, as integration across the clinical workflow enhances device value. For procurement and clinical leaders, supplier selection increasingly hinges on a combination of clinical evidence, supply chain reliability, post-market surveillance capabilities, and the vendor's willingness to engage in outcomes-based or value-based contracting frameworks.

Actionable strategic priorities that link clinical innovation, supply chain resilience, and commercial model evolution to capture long-term value

Industry leaders should adopt a multi-pronged strategy that balances innovation investment with operational resilience and commercial discipline. First, prioritize materials and design investments that align with clear clinical pain points, such as enhanced imaging compatibility, reduced operative time, or improved handling for minimally invasive approaches. Coupling product development with clinician co-design and targeted clinical pilots will accelerate meaningful adoption. Second, strengthen supply chain resilience by diversifying suppliers, developing regional manufacturing options where feasible, and improving visibility through advanced inventory and demand forecasting tools. This approach reduces exposure to tariff and trade volatility while preserving service levels.

Third, evolve commercial models to reflect stakeholder incentives; consider value-based contracting, bundled-service offerings, and clinically focused training programs that lower the barrier to adoption. Fourth, invest in post-market surveillance and real-world evidence generation to substantiate claims and support payer conversations. Finally, pursue selective partnerships with digital navigation and imaging providers to offer integrated solutions that enhance intraoperative precision. Taken together, these actions will enable organizations to deliver clinically meaningful innovation while managing risk and improving alignment with purchaser priorities.

A rigorous triangulated research methodology combining clinical interviews, regulatory analysis, and supply chain assessment to ensure reliable actionable insights

The research approach underpinning this analysis employs a triangulated methodology that synthesizes qualitative and quantitative inputs to produce robust, reproducible insights. Primary stakeholder engagement includes structured interviews with surgeons, procurement leaders, and clinical operations managers to capture practice patterns, purchasing drivers, and unmet needs. Secondary evidence was gathered through peer-reviewed clinical literature, regulatory filings, and technology whitepapers to validate clinical claims and to map device classifications and material properties.

Additionally, supply chain and procurement analyses were constructed from supplier disclosures, customs filings, and trade policy documentation to assess vulnerability points and sourcing strategies. Cross-validation exercises compared clinical inputs with supplier capabilities to identify alignment and gaps. Throughout, emphasis was placed on transparency of assumptions, documentation of data provenance, and sensitivity analysis where policy or market variables could materially influence strategic choices. This layered methodology supports actionable conclusions while acknowledging uncertainty and the need for ongoing monitoring of clinical, regulatory, and policy developments.

A concise synthesis of clinical, material, and commercial forces that converge to define resilience and opportunity in neurosurgery implant consumables

Modern neurosurgery implant consumables occupy a dynamic intersection of clinical demand, materials innovation, and procurement complexity. The landscape is characterized by steady innovation in polymer science and device geometry, deeper integration with digital surgical platforms, and increasing emphasis on supply chain robustness amid shifting trade policies. Clinical leaders are focused on solutions that demonstrably improve intraoperative efficiency and patient outcomes, while procurement stakeholders require evidence of value and reliable supply arrangements.

Looking ahead, manufacturers that integrate clinician-driven innovation with resilient sourcing and compelling real-world evidence will be best positioned to succeed. Strategic partnerships and integrated solutions will continue to erode traditional product siloes, and organizations that proactively adapt commercial models to align with payer and provider incentives will capture disproportionate value. In summary, success in this sector requires balancing clinical excellence, operational discipline, and commercial creativity to navigate an increasingly complex but opportunity-rich environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurosurgery Implant Consumable Market, by Product Type

  • 8.1. Cranial Plates
  • 8.2. Hemostatic Agents
  • 8.3. Pedicle Screws
  • 8.4. Spinal Rods

9. Neurosurgery Implant Consumable Market, by Material

  • 9.1. Composite Polymers
    • 9.1.1. Bioresorbable Polymers
    • 9.1.2. Carbon Fiber Composites
  • 9.2. Peek
  • 9.3. Stainless Steel
  • 9.4. Titanium

10. Neurosurgery Implant Consumable Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Specialty Clinics
    • 10.3.1. Neurology Clinics
    • 10.3.2. Spine Centers

11. Neurosurgery Implant Consumable Market, by Application

  • 11.1. Cranial
    • 11.1.1. Reconstruction
    • 11.1.2. Trauma Repair
  • 11.2. Spinal
    • 11.2.1. Cervical
    • 11.2.2. Lumbar
    • 11.2.3. Thoracic
  • 11.3. Trauma
    • 11.3.1. Dural Repair
    • 11.3.2. Skull Fracture Repair
  • 11.4. Tumor
    • 11.4.1. Biopsy Guidance
    • 11.4.2. Oncology Implants

12. Neurosurgery Implant Consumable Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurosurgery Implant Consumable Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurosurgery Implant Consumable Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Neurosurgery Implant Consumable Market

16. China Neurosurgery Implant Consumable Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Aesculap Implant Systems, LLC
  • 17.7. B. Braun SE
  • 17.8. Boston Scientific Corporation
  • 17.9. Craniotech Solutions Pvt. Ltd.
  • 17.10. DePuy Synthes, Inc.
  • 17.11. Globus Medical, Inc.
  • 17.12. Integra LifeSciences Corporation
  • 17.13. Johnson & Johnson Services, Inc.
  • 17.14. LivaNova PLC
  • 17.15. Medtronic plc
  • 17.16. Neuro France Implants SAS
  • 17.17. NuVasive, Inc.
  • 17.18. Orthofix Medical Inc.
  • 17.19. Penumbra, Inc.
  • 17.20. Siora Surgicals Pvt. Ltd.
  • 17.21. Smith & Nephew plc
  • 17.22. Stryker Corporation
  • 17.23. Terumo Corporation
  • 17.24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL PLATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL PLATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL PLATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEDICLE SCREWS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEDICLE SCREWS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEDICLE SCREWS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL RODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL RODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL RODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIORESORBABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIORESORBABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIORESORBABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CARBON FIBER COMPOSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CARBON FIBER COMPOSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CARBON FIBER COMPOSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEEK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEEK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PEEK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY NEUROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY NEUROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY RECONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY RECONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY RECONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CERVICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CERVICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CERVICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY LUMBAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY LUMBAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY LUMBAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY THORACIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY THORACIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY THORACIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY DURAL REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY DURAL REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY DURAL REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SKULL FRACTURE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SKULL FRACTURE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SKULL FRACTURE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIOPSY GUIDANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY BIOPSY GUIDANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY ONCOLOGY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY ONCOLOGY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY ONCOLOGY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 213. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 216. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 222. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 223. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 224. GCC NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 249. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 252. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 255. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 256. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 258. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 259. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 260. G7 NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 261. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 264. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 265. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 268. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 270. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 271. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 272. NATO NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY COMPOSITE POLYMERS, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY CRANIAL, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY SPINAL, 2018-2032 (USD MILLION)
  • TABLE 296. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TRAUMA, 2018-2032 (USD MILLION)
  • TABLE 297. CHINA NEUROSURGERY IMPLANT CONSUMABLE MARKET SIZE, BY TUMOR, 2018-2032 (USD MILLION)